DISCLOSURE OF FINANCIAL INTEREST. Principal Investigator shall ensure that he/she and collaborators and any member of the Research Staff involved in this Clinical Trial at Principal Investigator’s Clinical Trial Site provide Sponsor with the appropriate financial disclosures required for Sponsor’s compliance with CFR title 21 Part 54, on Sponsor’s request and on such forms as Sponsor may supply or approve. During the term of this Agreement and for one (1) year following termination or completion of the Clinical Trial, Principal Investigator shall promptly notify Sponsor of any material change in the information disclosed on a previous form. Parties may disclose the financial terms of this Agreement only if required by Law or transparency regulations.
Appears in 5 contracts
Samples: Trial Agreement, Trial Agreement, Trial Agreement
